More Middle East Pharmaceutical Industries Company news Middle East Pharmaceutical Industries CompanyTADAWUL: 4016 Avalon Pharma H2 Dividend Per Share SAR 1.32 Mar 8, 2026 at 1:16 PM UTC · Issued by Middle East Pharmaceutical Industries Company As issuedPlain English MIDDLE EAST PHARMACEUTICAL INDUSTRIES TADAWUL:4016:AVALON PHARMA H2 DIVIDEND PER SHARE SAR 1.32 Earlier from Middle East Pharmaceutical IndustriesAvalon Pharma FY Profit 97.01 Mln RiyalsMar 4Avalon Pharma Contract Sign Off With Bio-Thera SolutionsFeb 4Avalon Pharma Grants Three Bonus Shares For Every Four Shares HeldFeb 1Avalon Pharma Signs Non-Binding Memorandum Of Understanding With Benta SasNov 26, 2025All Middle East Pharmaceutical Industries news releases↗